Optimal management of polycystic ovary syndrome in adolescence (Q38535106)

3 September 2017

1 reference

title

Optimal management of polycystic ovary syndrome in adolescence (English)

1 reference

polycystic ovary syndrome

3 September 2017

0 references

1 reference

1 reference

Natalie Hecht Baldauff

series ordinal

1

1 reference

PubMed ID

26101431

3 September 2017

Silva Arslanian

series ordinal

2

1 reference

PubMed ID

26101431

3 September 2017

language of work or name

English

0 references

publication date

22 June 2015

1 reference

Archives of Disease in Childhood

3 September 2017

1 reference

3 September 2017

100

1 reference

3 September 2017

11

1 reference

3 September 2017

1076-1083

1 reference

The prevalence and features of the polycystic ovary syndrome in an unselected population

3 September 2017

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Reproductive endocrinology of adolescent polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Androgens before and after weight loss in obese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Functional significance of polycystic-size ovaries in healthy adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Androgen excess in women: experience with over 1000 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Prevalence of polycystic ovary syndrome in adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Menstrual health and the metabolic syndrome in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Glucose Intolerance, Insulin Resistance, and Hyperandrogenemia in First Degree Relatives of Women with Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Treatment of PCOS in adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Diagnosis of diabetes using hemoglobin A1c: should recommendations in adults be extrapolated to adolescents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Utility of hemoglobin A(1c) for diagnosing prediabetes and diabetes in obese children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Diabetes prevalence and risk factors in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Role of lifestyle modification in the management of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Effect of weight loss on menstrual function in adolescents with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Factors contributing to initial weight loss among adolescents with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Parents' Readiness to Change Affects BMI Reduction Outcomes in Adolescents with Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Cognitive-behavioral therapy for physical and emotional disturbances in adolescents with polycystic ovary syndrome: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

The evaluation and management of hirsutism*1

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Venous thromboembolism in women: a specific reproductive health risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Effect of rosiglitazone on insulin resistance, C-reactive protein and endothelial function in non-obese young women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Clinical assessment of body hair growth in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Clinical review: Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Evidence-based review of hair removal using lasers and light sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Comparison of alexandrite laser and electrolysis for hair removal

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Laser hair reduction in the hirsute patient: a critical assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

Intermittent Low-Dose Finasteride Administration Is Effective for Treatment of Hirsutism in Adolescent Girls: A Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FARCHDISCHILD-2014-306471

10.1136/ARCHDISCHILD-2014-306471

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference

PubMed ID

26101431